Preclinical Pharmacokinetics and In Vitro Metabolism of Asunaprevir (BMS-650032), a Potent Hepatitis C Virus NS3 Protease Inhibitor

Kathleen Mosure, Michael Sinz, Marc Browning et al.|Journal of Pharmaceutical Sciences|2015

Cited by 32